Novavax submits COVID-19 vaccine for approval by Health Canada

Biotechnology company Novavax Inc. says it has submitted its COVID-19 vaccine for approval in Canada. The U.S. company says it has now completed the submission of all modules required by Health Canada for the regulatory evaluation of its protein-based COVID-19 vaccine.